Koji Izutsu


AuthID: R-00H-XEA

Publications Awaiting Confirmation

1
TITLE: Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R-2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma
AUTHORS: Morschhauser, Franck; Nastoupil, Loretta; Feugier, Pierre; de Colella, Jean Marc Schiano; Tilly, Herve; Palomba, Maria Lia; Bachy, Emmanuel; Fruchart, Christophe; Libby, Edward N.; Casasnovas, Rene Olivier; Flinn, Ian W.; Haioun, Corinne; Maisonneuve, Herve; Ysebaert, Loic; Bartlett, Nancy L.; Bouabdallah, Kamal; Brice, Pauline; Ribrag, Vincent; Le Gouill, Steven; Daguindau, Nicolas; Guidez, Stephanie; Pica, Gian Matteo; Garcia Sancho, Alejandro Martin; Lopez Guillermo, Armondo; Larouche, Jean Francois; Ando, Kiyoshi; da Silva, Maria Gomes; Andre, Marc; Kalung, Wu; Sehn, Laurie H.; Izutsu, Koji; Cartron, Guillaume; Gkasiamis, Argyrios; Crowe, Russell; Xerri, Luc; Fowler, Nathan H.; Salles, Gilles; ...More
PUBLISHED: 2022, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 40, ISSUE: 28
INDEXED IN: Scopus WOS
2
TITLE: Six-Year Results from the Phase 3 Randomized Study Relevance Show Similar Outcomes for Previously Untreated Follicular Lymphoma Patients Receiving Lenalidomide Plus Rituximab (R (2)) Versus Rituximab-Chemotherapy Followed By Rituximab Maintenance
AUTHORS: Morschhauser, Franck; Nastoupil, Loretta; Feugier, Pierre; De Colella, Jean Marc Schiano; Tilly, Herve; Palomba, M. Lia; Bachy, Emmanuel; Fruchart, Christophe; Libby, Edward; Casasnovas, Rene Olivier; Flinn, Ian W.; Haioun, Corinne; Maisonneuve, Herve; Ysebaert, Loic; Bartlett, Nancy L.; Bouabdallah, Kamal; Brice, Pauline; Ribrag, Vincent; Le Gouill, Steven; Daguindau, Nicolas; Delwail, Vincent; Pica, Gian Matteo; Martin Garcia Sancho, Alejandro; Lopez Guillermo, Armando; Larouche, Jean Francois; Ando, Kiyoshi; Maria, Gomes da Silva; Andre, Marc; Wu, Ka Lung; Sehn, Laurie H.; Izutsu, Koji; Cartron, Guillaume; Gkasiamis, Argyrios; Crowe, Russell; Xerri, Luc; Fowler, Nathan H.; Salles, Gilles; ...More
PUBLISHED: 2021, SOURCE: BLOOD, VOLUME: 138
INDEXED IN: WOS
3
TITLE: Efficacy and time to next treatment following lenalidomide/rituximab (R-2) or rituximab/placebo in patients with R/R indolent NHL (AUGMENT).
AUTHORS: John G Gribben; Koji Izutsu; Nathan Hale Fowler; Xiaonan N Hong; Huilai L Zhang; Fritz Offner; Adriana A S Scheliga; Grzegorz S Nowakowski; Antonio Pinto; Francesca Re; Laura Maria Fogliatto; Phillip Scheinberg; Ian Flinn; Claudia Moreira; Stacey Anastasia Kalambakas; Pierre Fustier; Chengqing (Alan) Wu; John Paul Leonard;
PUBLISHED: 2019, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, ISSUE: 15
INDEXED IN: WOS
4
TITLE: AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
AUTHORS: John P Leonard; Marek Trneny; Koji Izutsu; Nathan H Fowler; Xiaonan N Hong; Jun Zhu; Huilai L Zhang; Fritz Offner; Adriana Scheliga; Grzegorz S Nowakowski; Antonio Pinto; Francesca Re; Laura Maria Fogliatto; Phillip Scheinberg; Ian W Flinn; Claudia Moreira; David Liu; Stacey Kalambakas; Pierre Fustier; Chengqing Q Wu; John G Gribben; ...More
PUBLISHED: 2018, SOURCE: 60th Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 132
INDEXED IN: WOS

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service